More

    Apollo Hospitals (Outperform) – The Hindu BusinessLine

    Goal: ₹9,036

    CMP: ₹6,374.90

    Apollo Hospitals Enterprise (APHS) Q3-FY25 EBITDA marginally missed BNPP/Bloomberg estimates by 2/3 per cent, owing to reasonably lower- than-expected progress within the hospital section. Hospitals/HealthCo/AHLL income grew 13/15/15 per cent y-o-y with 24.1 per cent EBITDA margin for the hospital section.

    Consolidated EBITDA got here in at 13.8 per cent (vs BNPPe 13.8 per cent). The GMV of the digital well being platform remained flat q-o-q at ₹760 crore. APHS highlighted that the continuing India/Bangladesh challenge impacted 1.5 per cent of hospital income and reaffirmed its ARPOB progress steering of 6 per cent for FY26/27.

    We stay upbeat on the Indian hospitals sector as we imagine it presents a number of progress drivers, like bettering occupancy of present beds, annual progress in ARPOB and bed-count growth. We view APHS as a powerful participant on this sector. We decrease our FY25-27E EBITDA by 1 per cent as we tweak our progress assumptions for the hospital section owing to fewer worldwide sufferers from Bangladesh on account of the continuing battle between two international locations resulting in issuance of fewer visas.

    We preserve our valuation parameters unchanged (incl. 29x FY27E goal EV/EBITDA for the hospital section and revise our TP to ₹9,036 (₹9,142 earlier).

    Stay in the Loop

    Get the daily email from CryptoNews that makes reading the news actually enjoyable. Join our mailing list to stay in the loop to stay informed, for free.

    Latest stories

    You might also like...